Metformin and Cardiometabolic Health in PCOS

Metformin is a widely used treatment for managing Polycystic Ovary Syndrome (PCOS), a condition affecting around 12% of women globally. Women with PCOS face higher risks of heart disease, strokes, and metabolic issues like insulin resistance, which impacts 50-70% of those with the condition. Metformin works by improving insulin sensitivity, lowering blood sugar levels, and reducing androgen production, which helps alleviate symptoms like acne and irregular periods.

Key takeaways:

• Heart and metabolic risks: Women with PCOS are 2.5 times more likely to have heart attacks and 1.71 times higher risk of strokes.
• Metformin’s role: Reduces insulin resistance, improves blood sugar control, and supports weight management (average weight loss: 6.9 lbs).
• Combination treatments: Pairing metformin with other therapies, like oral contraceptives or GLP-1 receptor agonists, can enhance results.
• Side effects: Common issues include nausea and diarrhea, but extended-release formulations help reduce these.

Metformin provides long-term benefits, including improved cholesterol levels, reduced blood pressure, and a 70% lower risk of major depression in women with PCOS. For personalized care, platforms like Oana Health offer telehealth consultations and home delivery, starting at $22/month.

Benefits of Metformin for Cardiometabolic Health

Insulin Resistance and Blood Sugar Control

Metformin works on multiple fronts to combat insulin resistance. It decreases glucose production in the liver, enhances muscle glucose uptake, and slows carbohydrate absorption. This combined approach helps lower circulating insulin levels throughout the body.

A meta-analysis of 24 randomized controlled trials revealed that metformin significantly reduced fasting blood glucose levels in women with PCOS, with a standardized mean difference of -0.23. Beyond managing blood sugar, it also reduces fatty acid synthesis while promoting fatty acid oxidation. Another benefit? It's used to treat acanthosis nigricans, those darkened patches of skin often linked to high insulin levels.

These metabolic improvements also play a role in regulating body weight.

Weight Management and BMI Reduction

Although metformin isn't classified as a weight loss drug, it can lead to modest reductions in weight. Studies show an average weight loss of about 3 kg and a BMI decrease of approximately 0.8 kg/m².

The weight loss effects are more noticeable when combined with lifestyle changes, such as a healthy diet and regular exercise. This is especially relevant for the 50% to 70% of women with PCOS who face obesity, a condition that increases cardiovascular risks. By addressing hyperinsulinemia - the key driver of weight gain and abdominal fat - metformin helps disrupt this harmful cycle.

Its benefits also extend to improving cholesterol levels and cardiovascular health.

Cholesterol Levels and Cardiovascular Risk Factors

Metformin has been shown to lower LDL cholesterol, with studies reporting a standardized mean difference of -0.41. However, its role as a standalone lipid-lowering agent is debated. For instance, the 2025 COMET-PCOS trial found that 26.2% of women on metformin alone still retained metabolic syndrome after 24 weeks.

"Our findings challenge the current practice of using metformin alone or with COCPs for lowering cardiometabolic risk." - Anuja Dokras, MD, PhD, University of Pennsylvania

Even so, metformin remains valuable in addressing multiple cardiovascular markers. In addition to improving cholesterol, it aids in reducing body weight, BMI, and fasting blood glucose - key factors in long-term heart health. Most users see measurable metabolic improvements within 6 to 12 months of starting the medication.

Metformin Compared to Other Treatment Options

Metformin Alone vs. Combination Treatments

Metformin’s role in managing metabolic issues makes it a key player in treating PCOS, but how does it stack up against other treatments? On its own, metformin may not always deliver the desired outcomes across all symptoms. Take the COMET-PCOS trial, for instance, conducted between January 2018 and June 2023 at the University of Pennsylvania. This study followed 240 women with hyperandrogenic PCOS and obesity. After 24 weeks of taking metformin (2,000 mg), 26.2% of participants still met the criteria for metabolic syndrome.

The choice of treatment often comes down to addressing specific symptoms. For example, oral contraceptive pills (OCPs) are particularly effective for tackling hirsutism and menstrual irregularities, whereas metformin is better suited for targeting insulin resistance and lowering triglycerides. Interestingly, combining metformin with OCPs can improve hirsutism more effectively than either treatment used alone. This suggests that while metformin is a strong option for insulin resistance, pairing it with other therapies can enhance overall results.

Another noteworthy combination is metformin with GLP-1 receptor agonists like liraglutide or semaglutide. This pairing leads to an average additional weight loss of 3.44 kg (7.6 lb) compared to metformin alone. Meanwhile, orlistat has shown better results than metformin in lowering testosterone levels and increasing HDL cholesterol.

Metformin with Diet and Exercise

When paired with lifestyle changes, metformin becomes even more effective. Women who combined metformin with diet and exercise saw a BMI reduction of 0.73 kg/m² and gained an average of 1.06 additional menstrual cycles over six months.

Dr. Helena Teede, Director of the Monash Centre for Health Research and Implementation, emphasizes the importance of this combined approach:

"Metformin has a role in addition to lifestyle in the management of PCOS. Lifestyle intervention is currently first-line treatment for women with PCOS in both prevention of weight gain and in weight loss... However, engagement, efficacy and sustainability of lifestyle intervention have proven challenging."

Beyond aiding weight loss, this combination therapy significantly reduces inflammation markers like IL-6, TNF, and C-reactive protein, outperforming metformin alone. It also shines when it comes to improving insulin sensitivity, as measured by HOMA-IR. Even modest weight loss - around 5% - can lead to noticeable improvements in PCOS symptoms. One study even documented a 3.4 kg (7.5 lb) weight loss over six months when lifestyle changes were combined with metformin. This underscores the importance of tailoring treatments to include both lifestyle adjustments and medication.

It’s worth noting that metformin can increase exercise heart rate, which might require adjustments to workout intensity.

Long-Term Safety and Effectiveness of Metformin

Long-Term Metabolic Improvements

Research spanning up to a decade confirms that metformin provides lasting metabolic benefits without introducing new safety concerns. The Diabetes Prevention Program (DPP) highlighted a 31% reduction in the risk of developing type 2 diabetes over 2.8 years. Even after 10 years, participants maintained an average weight loss of 5.5 lbs (2.5 kg).

Most benefits from metformin reach their peak around the six-month mark and then stabilize. This means users can expect consistent, long-term improvements, such as better menstrual regularity and enhanced hormonal balance. For women with PCOS, who face a high prevalence of insulin resistance - affecting about 60–70% - metformin's effects extend to improving cardiovascular health by reducing visceral fat and enhancing endothelial function. These benefits not only lower cardiovascular risks but also help maintain hormonal stability over time.

Metformin's impact isn't limited to metabolic health. Studies suggest it may reduce the odds of major depression by 70% in women with PCOS compared to those relying solely on lifestyle changes. Additionally, by restoring ovulation and countering unopposed estrogen, metformin might lower the risk of endometrial cancer.

While these long-term benefits are encouraging, regular monitoring for side effects remains essential during treatment.

Side Effects and Tolerability

Though metformin offers substantial benefits, its side effect profile warrants attention. Gastrointestinal issues are the most common complaint. In the COMET-PCOS trial, conducted at the University of Pennsylvania between January 2018 and June 2023, over 64% of participants reported diarrhea as a side effect. Other common symptoms include nausea, bloating, flatulence, and a metallic taste. Fortunately, these issues usually diminish as the body adjusts to the medication.

To minimize side effects, start with 500 mg once daily during a main meal for 1–2 weeks. Gradually increase the dose by 500 mg every one to two weeks until reaching a target of up to 2,500 mg/day. If side effects worsen during this process, maintaining the current dose for 2–4 weeks before any further increase can help. Extended-release formulations are another option to consider, as they often cause fewer gastrointestinal problems.

Long-term use comes with additional considerations. While a slight decline in hemoglobin and hematocrit levels is common during the first year of treatment, this typically doesn't progress further. However, 10–30% of patients may experience vitamin B12 absorption issues over time, making periodic screening a good precaution. The risk of lactic acidosis is extremely low; in fact, the DPPOS study reported zero cases during nearly 18,000 patient-years of follow-up. This rare complication is primarily a concern for individuals with pre-existing kidney or liver conditions.

sbb-itb-6dba428

Oana Health Treatment Options for PCOS

Metformin Treatment Plans at Oana Health

Oana Health offers carefully designed metformin-based therapies to address PCOS and cardiometabolic health. Patients can choose between two options: Oral Metformin ER at $22 per month, which targets insulin resistance and weight management, and a Metformin and Spironolactone combination at $32 per month, which also helps manage hyperandrogenic symptoms like acne and excess hair growth.

The extended-release (ER) formulation is designed to reduce gastrointestinal side effects, making it easier for patients to stick with the treatment while still achieving the same metabolic benefits. Through virtual consultations, Oana Health's expert providers customize each treatment plan, adjusting dosages based on how well the patient tolerates and responds to the medication. This personalized care approach fills a critical gap in PCOS management, especially given how often patients face delays or inadequate support when seeking medical advice.

For women with metabolic syndrome, the benefits of long-term metformin use can be significant. Studies show that after an average of 36.1 months, metformin treatment reduced the prevalence of metabolic syndrome from 34.3% to 21.4%. Improvements included a rise in HDL cholesterol levels (+5.82 mg/dL) and a drop in diastolic blood pressure (–2.69 mmHg). As noted by Kai I. Cheang, Pharm.D., M.S., from Virginia Commonwealth University:

"Metformin improved the metabolic profile of PCOS women over 36.1 months, particularly in HDL cholesterol, diastolic blood pressure and BMI".

These treatment options reflect the broader findings of sustained metabolic benefits in PCOS care and fit seamlessly into Oana Health's telehealth-driven approach.

Telehealth Access and Home Delivery

Oana Health’s telehealth platform makes consistent PCOS care more accessible and convenient. After completing a detailed online medical questionnaire, patients can have virtual consultations with licensed healthcare providers. These sessions address symptoms, treatment goals, and potential side effects. Medications are then delivered directly to the patient’s home at no additional cost, eliminating the hassle of pharmacy trips and supporting the consistency needed for long-term health improvements.

PCOS Part 1: Cardiovascular Risk | Dr. Sara Gottfried

Conclusion

Metformin has proven to be a valuable option for addressing cardiometabolic risks tied to PCOS. Studies show it can lead to weight loss (around 6.9 lbs), lower BMI (by 0.82 kg/m²), improve cholesterol levels, and regulate blood sugar. On top of that, it helps reduce androgen levels, alleviating symptoms like acne and excess hair growth. Women taking metformin are also reported to have 70% lower odds of major depression compared to those relying solely on lifestyle changes.

Over a span of about three years, metformin reduced the prevalence of metabolic syndrome from 34.3% to 21.4%, with notable improvements in HDL cholesterol and blood pressure. These benefits translate into meaningful protection against type 2 diabetes and cardiovascular disease.

The key to effective treatment is personalized care. PCOS symptoms vary greatly from person to person, so what works for one individual may not work for another. Starting with a low dose taken with food and keeping an eye on vitamin B12 levels can help ensure better tolerability.

For those seeking tailored solutions, Oana Health offers an accessible way to receive expert guidance. Through telehealth consultations and convenient home delivery, you can work with providers to design a treatment plan that meets your unique needs. Whether metformin alone or a combination therapy is right for you, options start at just $22 per month, with free shipping included. Managing PCOS doesn’t have to feel overwhelming or expensive.

If you're dealing with insulin resistance, weight concerns, or other PCOS-related challenges, a personalized treatment plan might be the next step in improving your overall cardiometabolic health.

FAQs

How does metformin improve insulin resistance in women with PCOS?

Metformin helps the body respond more effectively to insulin, which can lower insulin levels and manage blood sugar. This is especially helpful for women with PCOS, as insulin resistance is a common issue tied to the condition.

By boosting insulin sensitivity, metformin may also promote hormonal balance. This can lead to improvements in symptoms such as weight gain, irregular menstrual cycles, and other metabolic issues often associated with PCOS.

How can combining metformin with other treatments improve PCOS management?

Combining metformin with other treatments creates a comprehensive strategy for managing PCOS by tackling both metabolic and hormonal issues. For instance, using metformin alongside oral contraceptives can help balance hormones and regulate menstrual cycles, while metformin itself focuses on insulin resistance and metabolic improvements.

Adding lifestyle changes - like maintaining a balanced diet and staying active - can amplify the benefits. This approach may help lower insulin levels, ease symptoms such as acne and excess hair growth, and assist with weight management. Studies indicate that a tailored, multi-pronged treatment plan often yields better results for women dealing with PCOS, addressing challenges like obesity, insulin resistance, and potential cardiovascular concerns.

For a more personalized approach, services like Oana Health provide science-driven, customized treatments delivered conveniently to your doorstep.

What are the potential long-term effects of using metformin for managing PCOS?

Metformin is often prescribed to help manage symptoms of PCOS, especially when it comes to addressing insulin resistance and improving overall metabolic health. Studies show that its long-term use is generally well-tolerated and may offer benefits like enhanced insulin sensitivity, reduced cardiovascular risk factors, and assistance with weight management.

Most side effects, such as mild stomach discomfort, tend to appear early in treatment but usually fade with time. Current research hasn't identified any major long-term risks, though studies are ongoing to further assess its safety and effectiveness for prolonged use. It's important to consult your healthcare provider to determine if metformin is the right choice for your individual needs.